Beginning with lung diseases, Ebenbuild serves patients who suffer from severe illness by maximizing their health through unprecedented computational models that enable better and more efficient healthcare.

Based on scientific knowledge of physics, physiology, biochemistry, and the mechanisms of diseases, Ebenbuild develops ground-breaking personalized and predictive digital twins, focusing on personalized medicine which means understanding the individual first to derive empirical insights.

Ebenbuild's digital twin technology enables applications that bridge healthcare and life sciences with the core goal to maximize patient benefit.

The platform informs efficient and effective treatment decisions in hospitals, helps optimize drug delivery to lungs, tracks respiratory disease progression, and provides digital tools for precise decision-making to clinical and industrial users.